| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 6.743 | 28.049 | 36.387 | 33.458 | 19.650 | 1.608 |
| Total Income - EUR | - | - | - | - | 6.743 | 30.629 | 49.844 | 39.044 | 25.219 | 6.559 |
| Total Expenses - EUR | - | - | - | - | 14.291 | 29.274 | 32.089 | 16.642 | 16.581 | 5.431 |
| Gross Profit/Loss - EUR | - | - | - | - | -7.548 | 1.355 | 17.755 | 22.402 | 8.638 | 1.129 |
| Net Profit/Loss - EUR | - | - | - | - | -7.565 | 1.098 | 17.391 | 22.085 | 8.442 | 975 |
| Employees | - | - | - | - | 0 | 5 | 5 | 1 | 1 | 0 |
Check the financial reports for the company - Dexter S Laboratory S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 35.737 | 29.364 | 23.145 | 17.631 | 12.008 | 7.501 |
| Current Assets | - | - | - | - | 2.942 | 11.799 | 16.458 | 26.918 | 22.527 | 23.417 |
| Inventories | - | - | - | - | 2.069 | 2.438 | 2.384 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 0 | 0 | 11.491 | 217 | 2.734 |
| Cash | - | - | - | - | 873 | 9.361 | 14.074 | 15.427 | 22.309 | 20.683 |
| Shareholders Funds | - | - | - | - | -7.523 | -6.118 | 11.409 | 22.133 | 19.269 | 5.975 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 46.202 | 47.281 | 1.904 | 1.631 | 113 | 17.442 |
| Income in Advance | - | - | - | - | 0 | 0 | 26.289 | 20.785 | 15.153 | 7.501 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3250 - 3250" | |||||||||
| CAEN Financial Year |
3250
|
|||||||||
Comments - Dexter S Laboratory S.r.l.